Authors Details
A Real World Molecular Epidemiological Study of Non-Small-Cell Lung Cancer (NSCLC) Patients from Western India
The molecular characterization of advanced non-small-cell lung cancer (NSCLC) has unveiled genomic alterations such as EGFR gene mutations, KRAS gene mutations, ROS1 gene rearrangements, EML4-ALK rearrangements, and altered MET signaling. The objective of this molecular epidemiological study was to report the clinical, pathological, and molecular profile of NSCLC patients from western India.


-
Dr. Ashish Joshi
M.D (Internal Medicine)
D.M (Medical Oncology)Speciality - Medical and Pediatric Hemato-Oncologist.
Know More -
Dr. Kshitij Chandrakant Joshi
M.D (Internal Medicine)
D.M (Medical Oncology)
DNB (Diplomate of National Board)
ECMO (European Certification in Medical Oncology)Speciality - Medical and Pediatric Oncologist and Hematologist.
Know More -
Dr. Vashistha Pankaj Maniar
M.D (Internal Medicine)
D.M(Medical Oncology)
ECMO (European Society Certification in Medical Oncology)Speciality - Medical and Pediatric Hemato-Oncologist.
Know More -
Dr. Pritam Baban Kalaskar
M.D (Internal Medicine)
D.M (Medical Oncology)Speciality - Medical and Pediatric Hemato-Oncologist.
Know More -
Dr. Pradip Kendre
DNB (Internal Medicine)
D.M (Medical Oncology)Speciality - Medical and Pediatric Hemato-Oncologist.
Know More -
Dr. Udip Maheshwari
M.D. (Internal Medicine)
DNB (Medical oncology)
ECMO (European Society Certification in Medical Oncology)Speciality - Medical Oncologist and Hemato-Oncologist.
Know More -
Dr. Chandrashekhar Pethe
M.D (Internal Medicine)
D.M (Medical Oncology)Speciality - Medical Oncologist & Hemato-Oncologist.
Know More -
Dr. Smit Sheth
M.D (Internal Medicine)
D.M (Medical Oncology)
ECMO (European Society Certification in Medical Oncology)Speciality - Medical Oncologist and Hemato-Oncologist.
Know More -
Dr. Sonal Dhande
DNB (General Medicine)
DNB (Medical Oncology)Speciality - Medical Oncologist & Hemato-Oncologist.
Know More